C11 ER176 PET in Evaluating Neuroinflammation in Patients With Post-COVID Syndrome
Purpose
The purpose of this research is to find out if Positron Emission Tomography (PET) imaging with an investigational drug called C-11 ER176 can help us learn more about Post-COVID Syndrome.
Condition
- COVID-19
Eligibility
- Eligible Ages
- Over 18 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Mayo Clinic patients with a previously confirmed infection with the novel SARS-CoV-2 virus who have been seen in the Post COVID Clinic through GIM Integrative Medicine & Health Section or approval by MAGPIES research group. - Be able to participate fully in all aspects of the study. - Have understood and signed study informed consent.
Exclusion Criteria
- Lacking the capacity to consent. - Prisoners and institutionalized individuals. - Reports being currently pregnant, lactating, or are of child-bearing potential or are likely to become pregnant during the LLLT treatment phase and are unwilling to use a reliable form of contraception. o Acceptable forms include: - Hormonal methods, such as birth control pills, patches, injections, vaginal ring, or implants - Barrier methods (such as a condom or diaphragm) used with a spermicide (a foam, cream, or gel that kills sperm) - Intrauterine device (IUD) - Total hysterectomy or tubal ligation - Abstinence (no sex). - Those patients that have implants that would prevent them from having a PET Scan. - Patients that have claustrophobia. - Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
| Arm | Description | Assigned Intervention |
|---|---|---|
| Post Covid Syndrome | PET imaging through the C11 ER176 tracer |
|
Recruiting Locations
More Details
- NCT ID
- NCT07527130
- Status
- Not yet recruiting
- Sponsor
- Mayo Clinic